Avidity Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Avidity Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Avidity Biosciences Inc
Rating: 1.47183325
Author: Trendlyne DVM scores

about

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

43.21 0.91 (2.15%)

100.88% Gain from 52W Low

1.6M

XNAS Volume

XNAS 24 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.8 / 100

Technically Neutral

53.0 / 100

1Yr Price target upside is 58%

19 analysts

Avidity Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Avidity Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical...

100.88% Gain from 52W Low

SWOT Analysis

Avidity Biosciences Inc Live Price Chart